{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-24-000019","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.700707+00:00","generated_at":"2026-05-30T01:50:33.097388+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroPace Q3 revenue $21.1M (+28% YoY); raises FY2024 guidance to $78-80M","bullets":["Record quarterly revenue $21.1M vs $16.4M Q3 2023, driven by RNS System sales.","Net loss narrowed to $5.5M ($0.22 EPS) from $7.3M; operating loss $4.2M vs $6.0M.","Cash burn reduced to $1.8M from $2.3M; cash & investments $56.8M at quarter end.","Full-year 2024 revenue guidance raised to $78-80M (19-22% growth); gross margin guided 72-74%.","Appointed Brett Wingeier VP R&D, Katie Keller VP Marketing, Amy Treadwell VP HR."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-24-000019","json":"https://secwatch.observer/filing/0001528287-24-000019.json","markdown":"https://secwatch.observer/filing/0001528287-24-000019.md","text":"https://secwatch.observer/filing/0001528287-24-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828724000019/0001528287-24-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828724000019/npce-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:50:33.097388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}